San Diego, CA, United States of America

Eligio Reynoso

This inventor holds 1 USPTO granted patent. Top assignee: Anticancer, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eligio Reynoso. Retrieved from https://idiyas.com/inventor/eligio-reynoso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eligio Reynoso

Introduction

Eligio Reynoso is a notable inventor based in San Diego, California. He has made significant contributions to the field of biomedical research, particularly in the development of innovative models for studying tumor progression and gene expression.

Latest Patents

Reynoso holds a patent for "Immunocompromised rodents as dual color tumor models." This patent describes immunocompromised rodents that have been modified to express a fluorescent protein in substantially all tissues. These rodents serve as valuable models for understanding gene expression, tumor progression, and angiogenesis. The patent also includes model systems where heterologous tissues fluorescing in a first color are transplanted into hosts that fluoresce in a second color.

Career Highlights

Reynoso is associated with Anticancer, Inc., where he applies his expertise in developing advanced research models. His work has the potential to enhance the understanding of cancer biology and improve therapeutic strategies.

Collaborations

Reynoso collaborates with esteemed colleagues, including Meng Yang and Mingxu Xu, who contribute to the research efforts at Anticancer, Inc.

Conclusion

Eligio Reynoso's innovative work in developing dual color tumor models represents a significant advancement in cancer research. His contributions are paving the way for new insights into tumor biology and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…